DNA & Genetics Recursion’s Incoming CEO on Turning AI Drugs Into Clinical Proof PointsBy adminDecember 1, 20250 After twelve years at the helm of AI-drug developer Recursion, Chris Gibson will hand the CEO baton to Najat Khan,…
